Cargando…
Clinical implications of metastatic lymph node ratio in gastric cancer
BACKGROUND: The 5-year survival rate in patients with gastric cancer is still poor, and lymph node metastasis is considered one of the most important prognostic factors. However, there are controversies in the classification of lymph node metastasis in gastric cancer. This study was carried out to i...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194781/ https://www.ncbi.nlm.nih.gov/pubmed/17958880 http://dx.doi.org/10.1186/1471-2407-7-200 |
_version_ | 1782147693943980032 |
---|---|
author | Liu, Caigang Lu, Ping Lu, Yang Xu, Huimian Wang, Shubao Chen, Junqing |
author_facet | Liu, Caigang Lu, Ping Lu, Yang Xu, Huimian Wang, Shubao Chen, Junqing |
author_sort | Liu, Caigang |
collection | PubMed |
description | BACKGROUND: The 5-year survival rate in patients with gastric cancer is still poor, and lymph node metastasis is considered one of the most important prognostic factors. However, there are controversies in the classification of lymph node metastasis in gastric cancer. This study was carried out to investigate whether the metastatic lymph node ratio is a reliable classification of lymph node metastasis in gastric cancer in Chinese. METHODS: 224 cases with gastric cancer with more than D1 dissection were retrospectively reviewed. The association between the total number of resected lymph nodes and the number of metastatic lymph nodes was determined. The prognostic value of the metastastic node ratio, defined as the ratio of the number of metastatic lymph nodes over the total number of resected lymph nodes, and the pN classification was assessed. RESULTS: The number of metastatic lymph node increased with the number of total resected lymph nodes. A Cox regression revealed that the metastatic node ratio, the number of metastatic nodes, histological type, and histological growth pattern independently influenced prognosis. The 5-year survival rates were 78%, 61%, 25%, 0% in cases with a metastastic node ratio of 0%, > 0% but < 40%, 40–80%, > 80%, respectively (P < 0.001), and were 78%, 62%, 38%, 0% in cases with gastric cancer histologically classified as pN0, pN1, pN2, pN3, respectively (P < 0.001). CONCLUSION: The metastatic lymph node ratio is a simple and useful independent prognostic factor. It may obviate possible confounding factors that are related to stage migration, and should be considered as an important component in the lymph node category. |
format | Text |
id | pubmed-2194781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-21947812008-01-13 Clinical implications of metastatic lymph node ratio in gastric cancer Liu, Caigang Lu, Ping Lu, Yang Xu, Huimian Wang, Shubao Chen, Junqing BMC Cancer Research Article BACKGROUND: The 5-year survival rate in patients with gastric cancer is still poor, and lymph node metastasis is considered one of the most important prognostic factors. However, there are controversies in the classification of lymph node metastasis in gastric cancer. This study was carried out to investigate whether the metastatic lymph node ratio is a reliable classification of lymph node metastasis in gastric cancer in Chinese. METHODS: 224 cases with gastric cancer with more than D1 dissection were retrospectively reviewed. The association between the total number of resected lymph nodes and the number of metastatic lymph nodes was determined. The prognostic value of the metastastic node ratio, defined as the ratio of the number of metastatic lymph nodes over the total number of resected lymph nodes, and the pN classification was assessed. RESULTS: The number of metastatic lymph node increased with the number of total resected lymph nodes. A Cox regression revealed that the metastatic node ratio, the number of metastatic nodes, histological type, and histological growth pattern independently influenced prognosis. The 5-year survival rates were 78%, 61%, 25%, 0% in cases with a metastastic node ratio of 0%, > 0% but < 40%, 40–80%, > 80%, respectively (P < 0.001), and were 78%, 62%, 38%, 0% in cases with gastric cancer histologically classified as pN0, pN1, pN2, pN3, respectively (P < 0.001). CONCLUSION: The metastatic lymph node ratio is a simple and useful independent prognostic factor. It may obviate possible confounding factors that are related to stage migration, and should be considered as an important component in the lymph node category. BioMed Central 2007-10-24 /pmc/articles/PMC2194781/ /pubmed/17958880 http://dx.doi.org/10.1186/1471-2407-7-200 Text en Copyright © 2007 Liu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Liu, Caigang Lu, Ping Lu, Yang Xu, Huimian Wang, Shubao Chen, Junqing Clinical implications of metastatic lymph node ratio in gastric cancer |
title | Clinical implications of metastatic lymph node ratio in gastric cancer |
title_full | Clinical implications of metastatic lymph node ratio in gastric cancer |
title_fullStr | Clinical implications of metastatic lymph node ratio in gastric cancer |
title_full_unstemmed | Clinical implications of metastatic lymph node ratio in gastric cancer |
title_short | Clinical implications of metastatic lymph node ratio in gastric cancer |
title_sort | clinical implications of metastatic lymph node ratio in gastric cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194781/ https://www.ncbi.nlm.nih.gov/pubmed/17958880 http://dx.doi.org/10.1186/1471-2407-7-200 |
work_keys_str_mv | AT liucaigang clinicalimplicationsofmetastaticlymphnoderatioingastriccancer AT luping clinicalimplicationsofmetastaticlymphnoderatioingastriccancer AT luyang clinicalimplicationsofmetastaticlymphnoderatioingastriccancer AT xuhuimian clinicalimplicationsofmetastaticlymphnoderatioingastriccancer AT wangshubao clinicalimplicationsofmetastaticlymphnoderatioingastriccancer AT chenjunqing clinicalimplicationsofmetastaticlymphnoderatioingastriccancer |